Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 909

1.

A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF).

Masson R, Ambrosy AP, Kheder K, Fudim M, Clare RM, Coles A, Hernandez AF, Starling RC, Ezekowitz JA, O'Connor CM, Mentz RJ.

J Cardiovasc Transl Res. 2020 Jan 13. doi: 10.1007/s12265-020-09954-x. [Epub ahead of print]

PMID:
31933144
2.

Positive behaviour support in frontotemporal dementia: A pilot study.

O'Connor CMC, Mioshi E, Kaizik C, Fisher A, Hornberger M, Piguet O.

Neuropsychol Rehabil. 2020 Jan 3:1-24. doi: 10.1080/09602011.2019.1707099. [Epub ahead of print]

PMID:
31900056
3.

Risk factors associated with persistent chronic opioid use following THA.

Anoushiravani AA, Kim KY, Roof M, Chen K, O'Connor CM, Vigdorchik J, Schwarzkopf R.

Eur J Orthop Surg Traumatol. 2020 Jan 2. doi: 10.1007/s00590-019-02618-w. [Epub ahead of print]

PMID:
31897709
4.

The Heart Failure High Five: Medical Therapy and Policy: 2019.

O'Connor CM.

JACC Heart Fail. 2020 Jan;8(1):81-82. doi: 10.1016/j.jchf.2019.11.008. No abstract available.

PMID:
31896419
5.

Perspectives of Australian family carers of people with dementia on the 'cottage' model of respite: Compared to traditional models of residential respite provided in aged care facilities.

Harkin DJ, O'Connor CMC, Birch MR, Poulos CJ.

Health Soc Care Community. 2019 Dec 20. doi: 10.1111/hsc.12916. [Epub ahead of print]

PMID:
31863540
6.

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.

Butler J, Packer M, Greene SJ, Fiuzat M, Anker SD, Anstrom KJ, Carson PE, Cooper LB, Fonarow GC, Hernandez AF, Januzzi JL Jr, Jessup M, Kalyani RR, Kaul S, Kosiborod M, Lindenfeld J, McGuire DK, Sabatine MS, Solomon SD, Teerlink JR, Vaduganathan M, Yancy CW, Stockbridge N, O'Connor CM.

Circulation. 2019 Dec 17;140(25):2108-2118. doi: 10.1161/CIRCULATIONAHA.119.042155. Epub 2019 Dec 16.

PMID:
31841369
7.

Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.

Pieske B, Patel MJ, Westerhout CM, Anstrom KJ, Butler J, Ezekowitz J, Hernandez AF, Koglin J, Lam CSP, Ponikowski P, Roessig L, Voors AA, O'Connor CM, Armstrong PW; VICTORIA Study Group.

Eur J Heart Fail. 2019 Dec;21(12):1596-1604. doi: 10.1002/ejhf.1664. Epub 2019 Dec 9.

PMID:
31820546
8.

Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission.

Pandhi P, Ter Maaten JM, Emmens JE, Struck J, Bergmann A, Cleland JG, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Cotter G, Davison B, van Veldhuisen DJ, Voors AA.

Eur J Heart Fail. 2019 Dec 3. doi: 10.1002/ejhf.1693. [Epub ahead of print]

PMID:
31797505
9.

Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency.

Elder EG, Krishna BA, Williamson J, Lim EY, Poole E, Sedikides GX, Wills M, O'Connor CM, Lehner PJ, Sinclair J.

mBio. 2019 Dec 3;10(6). pii: e02574-19. doi: 10.1128/mBio.02574-19.

10.

N-1 and Sequencing Clinical Heart Failure Trials: Charting the Path for Future Clinical Care.

O'Connor CM.

JACC Heart Fail. 2019 Dec;7(12):1089-1090. doi: 10.1016/j.jchf.2019.10.006. No abstract available.

PMID:
31779932
11.

Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction.

Regan JA, Kitzman DW, Leifer ES, Kraus WE, Fleg JL, Forman DE, Whellan DJ, Wojdyla D, Parikh K, O'Connor CM, Mentz RJ.

JACC Heart Fail. 2019 Dec;7(12):1056-1065. doi: 10.1016/j.jchf.2019.09.004.

PMID:
31779928
12.

Clinical Implications of the New York Heart Association Classification.

Caraballo C, Desai NR, Mulder H, Alhanti B, Wilson FP, Fiuzat M, Felker GM, Piña IL, O'Connor CM, Lindenfeld J, Januzzi JL, Cohen LS, Ahmad T.

J Am Heart Assoc. 2019 Dec 3;8(23):e014240. doi: 10.1161/JAHA.119.014240. Epub 2019 Nov 27.

13.

Cat-to-Human Transmission of Mycobacterium bovis, United Kingdom.

O'Connor CM, Abid M, Walsh AL, Behbod B, Roberts T, Booth LV, Thomas HL, Smith NH, Palkopoulou E, Dale J, Nunez-Garcia J, Morgan D.

Emerg Infect Dis. 2019 Dec;25(12):2284-2286. doi: 10.3201/eid2512.190012.

14.

A Call for Change: Level of Statistical Significance.

O'Connor CM.

JACC Heart Fail. 2019 Nov;7(11):993-994. doi: 10.1016/j.jchf.2019.09.005. No abstract available.

PMID:
31672309
15.

PARAGON-HF - Why We Do Randomized, Controlled Clinical Trials.

O'Connor CM, deFilippi C.

N Engl J Med. 2019 Oct 24;381(17):1675-1676. doi: 10.1056/NEJMe1912402. No abstract available.

PMID:
31644849
16.

Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality.

Beusekamp JC, Tromp J, Cleland JGF, Givertz MM, Metra M, O'Connor CM, Teerlink JR, Ponikowski P, Ouwerkerk W, van Veldhuisen DJ, Voors AA, van der Meer P.

JACC Heart Fail. 2019 Nov;7(11):970-979. doi: 10.1016/j.jchf.2019.07.010. Epub 2019 Oct 9.

PMID:
31606364
17.

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.

Greene SJ, DeVore AD, Sheng S, Fonarow GC, Butler J, Califf RM, Hernandez AF, Matsouaka RA, Samman Tahhan A, Thomas KL, Vaduganathan M, Yancy CW, Peterson ED, O'Connor CM, Mentz RJ.

JACC Heart Fail. 2019 Nov;7(11):980-992. doi: 10.1016/j.jchf.2019.07.011. Epub 2019 Oct 9.

PMID:
31606362
18.

The Hospital Readmissions Reduction Program: Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper.

Psotka MA, Fonarow GC, Allen LA, Joynt Maddox KE, Fiuzat M, Heidenreich P, Hernandez AF, Konstam MA, Yancy CW, O'Connor CM.

JACC Heart Fail. 2020 Jan;8(1):1-11. doi: 10.1016/j.jchf.2019.07.012. Epub 2019 Oct 9. Review.

PMID:
31606360
19.

Acute Decompensated Heart Failure: Is There a Path Forward?

O'Connor CM.

JACC Heart Fail. 2019 Oct;7(10):911-912. doi: 10.1016/j.jchf.2019.08.005. No abstract available.

PMID:
31582109
20.

Protein phosphatase 2A controls ongoing DNA replication by binding to and regulating cell division cycle 45 (CDC45).

Perl AL, O'Connor CM, Fa P, Mayca Pozo F, Zhang J, Zhang Y, Narla G.

J Biol Chem. 2019 Nov 8;294(45):17043-17059. doi: 10.1074/jbc.RA119.010432. Epub 2019 Sep 27.

PMID:
31562245
21.

Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction.

DeVore AD, Yow E, Krucoff MW, Sherwood MW, Shaw LK, Chiswell K, O'Connor CM, Ohman EM, Velazquez EJ.

ESC Heart Fail. 2019 Sep 27. doi: 10.1002/ehf2.12510. [Epub ahead of print]

22.

Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors.

O'Connor CM, Leonard D, Wiredja D, Avelar RA, Wang Z, Schlatzer D, Bryson B, Tokala E, Taylor SE, Upadhyay A, Sangodkar J, Gingras AC, Westermarck J, Xu W, DiFeo A, Brautigan DL, Haider S, Jackson M, Narla G.

Oncogene. 2020 Jan;39(3):703-717. doi: 10.1038/s41388-019-1012-2. Epub 2019 Sep 20.

PMID:
31541192
23.

Heart Failure Physician Burnout: How Can We Help?

O'Connor CM.

JACC Heart Fail. 2019 Sep;7(9):821. doi: 10.1016/j.jchf.2019.07.004. No abstract available.

PMID:
31466675
24.

Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction.

Januzzi JL Jr, Ahmad T, Mulder H, Coles A, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Mark DB, Piña IL, Passmore G, Whellan DJ, Cooper LS, Leifer ES, Desvigne-Nickens P, Felker GM, O'Connor CM.

J Am Coll Cardiol. 2019 Sep 3;74(9):1205-1217. doi: 10.1016/j.jacc.2019.06.055.

PMID:
31466618
25.
26.

Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development.

Psotka MA, Fiuzat M, Carson PE, Kao DP, Cerkvenik J, Schaber DE, Verta P, Kazmierski RT, Shinnar M, Stockbridge N, Unger EF, Zuckerman B, Butler J, Felker GM, Konstam MA, Lindenfeld J, Solomon SD, Teerlink JR, O'Connor CM, Abraham WT.

JACC Heart Fail. 2019 Nov;7(11):913-921. doi: 10.1016/j.jchf.2019.07.001. Epub 2019 Aug 7. Review.

27.

Why Should We Publish All Clinical Trials?

O'Connor CM.

JACC Heart Fail. 2019 Aug;7(8):730. doi: 10.1016/j.jchf.2019.06.009. No abstract available.

PMID:
31370967
28.

Reply: Standardized and Tailored Approach to Therapies for Cardiogenic Shock.

Tehrani BN, O'Connor CM.

J Am Coll Cardiol. 2019 Jul 30;74(4):593-594. doi: 10.1016/j.jacc.2019.05.039. No abstract available.

PMID:
31345439
29.

Trajectories of Changes in Renal Function in Patients with Acute Heart Failure.

Beldhuis IE, Streng KW, van der Meer P, Ter Maaten JM, O'Connor CM, Metra M, Dittrich HC, Ponikowski P, Cotter G, Cleland JGF, Davison BA, Givertz MM, Teerlink JR, Bloomfield DM, Voors AA, Damman K.

J Card Fail. 2019 Nov;25(11):866-874. doi: 10.1016/j.cardfail.2019.07.004. Epub 2019 Jul 15.

30.

N-of-1 Clinical Trials.

O'Connor CM.

JACC Heart Fail. 2019 Jul;7(7):630-631. doi: 10.1016/j.jchf.2019.05.004. No abstract available.

PMID:
31248572
31.

Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.

Yang S, Starks MA, Hernandez AF, Turner EL, Califf RM, O'Connor CM, Mentz RJ, Roy Choudhury K.

Contemp Clin Trials. 2020 Jan;88:105775. doi: 10.1016/j.cct.2019.04.016. Epub 2019 Jun 20.

PMID:
31228563
32.

Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972].

Ambrosy AP, Mentz RJ, Fiuzat M, Cleland JGF, Greene SJ, O'Connor CM, Teerlink JR, Zannad F, Solomon SD.

Eur J Heart Fail. 2019 Jun;21(6):819. doi: 10.1002/ejhf.1480. Epub 2019 May 9. No abstract available.

PMID:
31222927
33.

Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions.

Reddy YNV, Borlaug BA, O'Connor CM, Gersh BJ.

Eur Heart J. 2019 Jun 14. pii: ehz364. doi: 10.1093/eurheartj/ehz364. [Epub ahead of print]

PMID:
31199474
34.

Rationale and design for the development of a novel nitroxyl donor in patients with acute heart failure.

Felker GM, Borentain M, Cleland JG, DeSouza MM, Kessler PD, O'Connor CM, Seiffert D, Teerlink JR, Voors AA, McMurray JJV.

Eur J Heart Fail. 2019 Aug;21(8):1022-1031. doi: 10.1002/ejhf.1504. Epub 2019 Jun 6.

PMID:
31168885
35.

African Americans With Advanced Heart Failure Are More Likely to Die in a Health Care Facility Than at Home or in Hospice: An Analysis From the PAL-HF Trial.

Warraich HJ, O'Connor CM, Yang H, Granger BB, Johnson KS, Mark DB, Anstrom KJ, Patel CB, Steinhauser KE, Tulsky JA, Taylor DH Jr, Rogers JG, Mentz RJ.

J Card Fail. 2019 Aug;25(8):693-694. doi: 10.1016/j.cardfail.2019.05.013. Epub 2019 May 31. No abstract available.

PMID:
31158470
36.

Correction: Two purified domains of telomerase reverse transcriptase reconstitute sequence-specific interactions with RNA.

O'Connor CM, Lai CK, Collins K.

J Biol Chem. 2019 May 31;294(22):8713. doi: 10.1074/jbc.AAC119.009170. No abstract available.

37.

Better Quality of Life Over More Quantity of Life: How We View Time Trade-Off.

O'Connor CM.

JACC Heart Fail. 2019 Jun;7(6):531-532. doi: 10.1016/j.jchf.2019.05.001. No abstract available.

PMID:
31146877
38.

The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis.

Taylor SE, O'Connor CM, Wang Z, Shen G, Song H, Leonard D, Sangodkar J, LaVasseur C, Avril S, Waggoner S, Zanotti K, Armstrong AJ, Nagel C, Resnick K, Singh S, Jackson MW, Xu W, Haider S, DiFeo A, Narla G.

Cancer Res. 2019 Aug 15;79(16):4242-4257. doi: 10.1158/0008-5472.CAN-19-0218. Epub 2019 May 29.

PMID:
31142515
39.

Rationale and Design of the VITALITY-HFpEF Trial.

Butler J, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O'Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, Wu Y, Carvalho F, Bamber L, Blaustein RO, Roessig L, Armstrong PW.

Circ Heart Fail. 2019 May;12(5):e005998. doi: 10.1161/CIRCHEARTFAILURE.119.005998.

PMID:
31096775
40.

Guideline-Directed Medical Therapy Clinics: A Call to Action for the Heart Failure Team.

O'Connor CM.

JACC Heart Fail. 2019 May;7(5):442-443. doi: 10.1016/j.jchf.2019.04.001. No abstract available.

PMID:
31047024
41.

Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey.

Psotka MA, Ammon SE, Fiuzat M, Bozkurt B, Chung ES, Cole RT, Greene SJ, Kraus D, Ky B, McIlvennan CK, Shah P, Teerlink JR, Walsh MN, Jessup M, O'Connor CM.

JACC Heart Fail. 2019 May;7(5):431-438. doi: 10.1016/j.jchf.2019.02.008. Epub 2019 Apr 10.

PMID:
30981742
42.

Standardized Team-Based Care for Cardiogenic Shock.

Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, Singh R, Psotka M, Shah P, Cooper LB, Rosner C, Raja A, Barnett SD, Saulino P, deFilippi CR, Gurbel PA, Murphy CE, O'Connor CM.

J Am Coll Cardiol. 2019 Apr 9;73(13):1659-1669. doi: 10.1016/j.jacc.2018.12.084. Erratum in: J Am Coll Cardiol. 2019 Jul 23;74(3):481.

43.

Heart Failure Fake News: How Do We Distinguish the Truth?

O'Connor CM.

JACC Heart Fail. 2019 Apr;7(4):363. doi: 10.1016/j.jchf.2019.02.004. No abstract available.

PMID:
30922511
44.

Heart Failure in Women.

Lindenfeld J, O'Connor CM.

JACC Heart Fail. 2019 Mar;7(3):274-275. doi: 10.1016/j.jchf.2019.01.012. No abstract available.

PMID:
30819385
45.

Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

Vaduganathan M, Tahhan AS, Alrohaibani A, Greene SJ, Fonarow GC, Vardeny O, Lindenfeld J, Jessup M, Fiuzat M, O'Connor CM, Butler J.

JACC Heart Fail. 2019 Mar;7(3):267-271. doi: 10.1016/j.jchf.2018.12.016. Review. No abstract available.

PMID:
30819383
46.

Protein phosphatase 2A Aα regulates Aβ protein expression and stability.

O'Connor CM, Hoffa MT, Taylor SE, Avelar RA, Narla G.

J Biol Chem. 2019 Apr 12;294(15):5923-5934. doi: 10.1074/jbc.RA119.007593. Epub 2019 Feb 22.

PMID:
30796164
47.

Author Correction: Direct benefits and evolutionary transitions to complex societies.

Dey CJ, O'Connor CM, Wilkinson H, Shultz S, Balshine S, Fitzpatrick JL.

Nat Ecol Evol. 2019 Mar;3(3):500. doi: 10.1038/s41559-019-0830-5.

PMID:
30760916
48.

Recognizing Heart Failure Awareness Week.

O'Connor CM.

JACC Heart Fail. 2019 Feb;7(2):173. doi: 10.1016/j.jchf.2018.12.013. No abstract available.

PMID:
30704606
49.

Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Krishna BA, Humby MS, Miller WE, O'Connor CM.

Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1755-1764. doi: 10.1073/pnas.1816933116. Epub 2019 Jan 15.

50.

NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF.

Daubert MA, Adams K, Yow E, Barnhart HX, Douglas PS, Rimmer S, Norris C, Cooper L, Leifer E, Desvigne-Nickens P, Anstrom K, Fiuzat M, Ezekowitz J, Mark DB, O'Connor CM, Januzzi J, Felker GM.

JACC Heart Fail. 2019 Feb;7(2):158-168. doi: 10.1016/j.jchf.2018.10.014. Epub 2019 Jan 2.

PMID:
30611722

Supplemental Content

Loading ...
Support Center